7.2 Bladder Instillation and Urological Surgery
First line drugs | Second line drugs | Specialist drugs | Secondary care drugs |
Traffic light status (TLS) explained:
- Green: Routine prescribing within licensed indication
- Amber 1: specialist recommendation followed by GP initiation and continuation
- Amber 2: specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation
- Amber 3: specialist initiation and stabilisation followed by GP continuation
- Amber SCG: specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline
- Red: Hospital or specialist prescribing only
- Double Red: These medicines have been evaluated and rejected by MKPAG and are NOT approved for use within MK. They are not recommended for use because of lack of clinical effectiveness, cost effectiveness or safety.
7.2 Bladder installations and urological surgery
Water for Irrigation
- 1 Litre
Antiseptic and Disinfectants
Chlorhexidine with Lidocaine gel (Instillagel)
Irrigating Solutions
Glycine 1.5% with ethanol 1%
Urological Anti-inflammatory drugs
Dimethyl sulfoxide (RIMSO-50)
Catheter maintenance solutions
Sodium chloride
- 0.9% irrigation solution
- 1 litre
- 3 litre
- Uro-Tainer
- Pour bottle.
Solution G
- Suby G Uro-Tainer
Others
iAluRil® solution
- Contains Sodium hyaluronate/sodium chondroitin sulfate 800mg/1g per 50ml, soln in pre-filled syringe
Traffic light status (TLS) explained:
- Green: Routine prescribing within licensed indication
- Amber 1: specialist recommendation followed by GP initiation and continuation
- Amber 2: specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation
- Amber 3: specialist initiation and stabilisation followed by GP continuation
- Amber SCG: specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline
- Red: Hospital or specialist prescribing only
- Double Red: These medicines have been evaluated and rejected by MKPAG and are NOT approved for use within MK. They are not recommended for use because of lack of clinical effectiveness, cost effectiveness or safety.
Return to Chapter: 7. Obstetrics, Gynaecology and Urinary-tract Disorders
Last updated by: Dupe Fagbenro on 22-02-2019 09:17